

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.26193087 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.26193087 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.92280592 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.92280592 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.12255440 |
| 6 | protein maturation by protein folding (GO:0022417) | 5.51941773 |
| 7 | bile acid biosynthetic process (GO:0006699) | 5.28889751 |
| 8 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.25759018 |
| 9 | glyoxylate metabolic process (GO:0046487) | 5.19800322 |
| 10 | indole-containing compound catabolic process (GO:0042436) | 5.11396858 |
| 11 | indolalkylamine catabolic process (GO:0046218) | 5.11396858 |
| 12 | tryptophan catabolic process (GO:0006569) | 5.11396858 |
| 13 | tryptophan metabolic process (GO:0006568) | 4.93946636 |
| 14 | sulfur amino acid catabolic process (GO:0000098) | 4.82336106 |
| 15 | regulation of fibrinolysis (GO:0051917) | 4.76174559 |
| 16 | high-density lipoprotein particle remodeling (GO:0034375) | 4.72314902 |
| 17 | negative regulation of fibrinolysis (GO:0051918) | 4.72125112 |
| 18 | kynurenine metabolic process (GO:0070189) | 4.71706330 |
| 19 | cysteine metabolic process (GO:0006534) | 4.65453818 |
| 20 | * protein carboxylation (GO:0018214) | 4.64658340 |
| 21 | * peptidyl-glutamic acid carboxylation (GO:0017187) | 4.64658340 |
| 22 | regulation of protein activation cascade (GO:2000257) | 4.58225148 |
| 23 | alpha-linolenic acid metabolic process (GO:0036109) | 4.56586806 |
| 24 | aromatic amino acid family metabolic process (GO:0009072) | 4.50937683 |
| 25 | complement activation, alternative pathway (GO:0006957) | 4.49361108 |
| 26 | bile acid metabolic process (GO:0008206) | 4.48458764 |
| 27 | tyrosine metabolic process (GO:0006570) | 4.40694391 |
| 28 | aldehyde catabolic process (GO:0046185) | 4.35135285 |
| 29 | regulation of cholesterol esterification (GO:0010872) | 4.32662058 |
| 30 | regulation of complement activation (GO:0030449) | 4.31309692 |
| 31 | urea cycle (GO:0000050) | 4.27657506 |
| 32 | urea metabolic process (GO:0019627) | 4.27657506 |
| 33 | protein retention in ER lumen (GO:0006621) | 4.26277664 |
| 34 | serine family amino acid catabolic process (GO:0009071) | 4.15007063 |
| 35 | coenzyme catabolic process (GO:0009109) | 4.10635069 |
| 36 | triglyceride homeostasis (GO:0070328) | 4.10254856 |
| 37 | acylglycerol homeostasis (GO:0055090) | 4.10254856 |
| 38 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.07348618 |
| 39 | nitrogen cycle metabolic process (GO:0071941) | 4.04140073 |
| 40 | reverse cholesterol transport (GO:0043691) | 4.04072967 |
| 41 | opsonization (GO:0008228) | 4.03167718 |
| 42 | plasma lipoprotein particle remodeling (GO:0034369) | 4.01959622 |
| 43 | protein-lipid complex remodeling (GO:0034368) | 4.01959622 |
| 44 | macromolecular complex remodeling (GO:0034367) | 4.01959622 |
| 45 | regulation of triglyceride catabolic process (GO:0010896) | 4.01153471 |
| 46 | homocysteine metabolic process (GO:0050667) | 3.97237951 |
| 47 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.94598250 |
| 48 | blood coagulation, intrinsic pathway (GO:0007597) | 3.91886199 |
| 49 | cellular glucuronidation (GO:0052695) | 3.91312423 |
| 50 | alpha-amino acid catabolic process (GO:1901606) | 3.90404559 |
| 51 | cofactor catabolic process (GO:0051187) | 3.88295073 |
| 52 | fibrinolysis (GO:0042730) | 3.85733838 |
| 53 | serine family amino acid biosynthetic process (GO:0009070) | 3.85093267 |
| 54 | indolalkylamine metabolic process (GO:0006586) | 3.82573494 |
| 55 | cellular ketone body metabolic process (GO:0046950) | 3.80885409 |
| 56 | cellular biogenic amine catabolic process (GO:0042402) | 3.80764730 |
| 57 | amine catabolic process (GO:0009310) | 3.80764730 |
| 58 | phospholipid efflux (GO:0033700) | 3.78417348 |
| 59 | bile acid and bile salt transport (GO:0015721) | 3.77863879 |
| 60 | amino-acid betaine metabolic process (GO:0006577) | 3.77255970 |
| 61 | glycine metabolic process (GO:0006544) | 3.75938807 |
| 62 | plasma lipoprotein particle clearance (GO:0034381) | 3.70215863 |
| 63 | serine family amino acid metabolic process (GO:0009069) | 3.69551854 |
| 64 | chaperone-mediated protein transport (GO:0072321) | 3.69286941 |
| 65 | cellular amino acid catabolic process (GO:0009063) | 3.66498535 |
| 66 | glucuronate metabolic process (GO:0019585) | 3.65832103 |
| 67 | uronic acid metabolic process (GO:0006063) | 3.65832103 |
| 68 | imidazole-containing compound metabolic process (GO:0052803) | 3.61701172 |
| 69 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.58390343 |
| 70 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.58390343 |
| 71 | cholesterol efflux (GO:0033344) | 3.57182409 |
| 72 | 4-hydroxyproline metabolic process (GO:0019471) | 3.55280447 |
| 73 | benzene-containing compound metabolic process (GO:0042537) | 3.53147945 |
| 74 | regulation of plasminogen activation (GO:0010755) | 3.51662288 |
| 75 | heme transport (GO:0015886) | 3.49061364 |
| 76 | fatty acid elongation (GO:0030497) | 3.47472413 |
| 77 | negative regulation of sterol transport (GO:0032372) | 3.47285430 |
| 78 | negative regulation of cholesterol transport (GO:0032375) | 3.47285430 |
| 79 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.43103285 |
| 80 | low-density lipoprotein particle remodeling (GO:0034374) | 3.41729850 |
| 81 | protein complex biogenesis (GO:0070271) | 3.36890803 |
| 82 | ethanol oxidation (GO:0006069) | 3.34849656 |
| 83 | lysine catabolic process (GO:0006554) | 3.34585667 |
| 84 | lysine metabolic process (GO:0006553) | 3.34585667 |
| 85 | carboxylic acid catabolic process (GO:0046395) | 3.34452796 |
| 86 | organic acid catabolic process (GO:0016054) | 3.34452796 |
| 87 | arginine metabolic process (GO:0006525) | 3.34094074 |
| 88 | protein activation cascade (GO:0072376) | 3.33811190 |
| 89 | very long-chain fatty acid metabolic process (GO:0000038) | 3.32683034 |
| 90 | cellular modified amino acid catabolic process (GO:0042219) | 3.32599445 |
| 91 | negative regulation of lipase activity (GO:0060192) | 3.32469467 |
| 92 | GDP-mannose metabolic process (GO:0019673) | 3.31819832 |
| 93 | ketone body metabolic process (GO:1902224) | 3.27391987 |
| 94 | L-serine metabolic process (GO:0006563) | 3.26757313 |
| 95 | short-chain fatty acid metabolic process (GO:0046459) | 3.26265351 |
| 96 | response to nitrosative stress (GO:0051409) | 3.25950822 |
| 97 | cholesterol homeostasis (GO:0042632) | 3.25152693 |
| 98 | plasma lipoprotein particle assembly (GO:0034377) | 3.24639546 |
| 99 | drug transmembrane transport (GO:0006855) | 3.23556937 |
| 100 | complement activation, classical pathway (GO:0006958) | 3.23246836 |
| 101 | complement activation (GO:0006956) | 3.23032340 |
| 102 | peptidyl-proline hydroxylation (GO:0019511) | 3.19675433 |
| 103 | sterol homeostasis (GO:0055092) | 3.17419705 |
| 104 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.17384368 |
| 105 | respiratory chain complex IV assembly (GO:0008535) | 3.16552512 |
| 106 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.16266259 |
| 107 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.15691629 |
| 108 | monocarboxylic acid catabolic process (GO:0072329) | 3.13137171 |
| 109 | type B pancreatic cell proliferation (GO:0044342) | 3.11468568 |
| 110 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.11022973 |
| 111 | fatty acid beta-oxidation (GO:0006635) | 3.10060467 |
| 112 | cellular response to zinc ion (GO:0071294) | 3.08728672 |
| 113 | fatty acid oxidation (GO:0019395) | 3.08648846 |
| 114 | regulation of cholesterol metabolic process (GO:0090181) | 3.08090773 |
| 115 | fatty acid catabolic process (GO:0009062) | 3.07996567 |
| 116 | GTP biosynthetic process (GO:0006183) | 3.05315957 |
| 117 | regulation of mitochondrial translation (GO:0070129) | 3.02864529 |
| 118 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.02076225 |
| 119 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.00703389 |
| 120 | ATP synthesis coupled proton transport (GO:0015986) | 3.00703389 |
| 121 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.99067209 |
| 122 | positive regulation of TOR signaling (GO:0032008) | 2.98711615 |
| 123 | respiratory electron transport chain (GO:0022904) | 2.98495885 |
| 124 | cytochrome complex assembly (GO:0017004) | 2.95798365 |
| 125 | xenobiotic catabolic process (GO:0042178) | 2.95796577 |
| 126 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.92964013 |
| 127 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.92836347 |
| 128 | electron transport chain (GO:0022900) | 2.92482998 |
| 129 | protein neddylation (GO:0045116) | 2.90094835 |
| 130 | proteasome assembly (GO:0043248) | 2.89810350 |
| 131 | CTP biosynthetic process (GO:0006241) | 2.86541860 |
| 132 | CTP metabolic process (GO:0046036) | 2.86541860 |
| 133 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.85893818 |
| 134 | NADH dehydrogenase complex assembly (GO:0010257) | 2.85893818 |
| 135 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.85893818 |
| 136 | protein targeting to mitochondrion (GO:0006626) | 2.85595590 |
| 137 | adhesion of symbiont to host cell (GO:0044650) | 2.84604619 |
| 138 | virion attachment to host cell (GO:0019062) | 2.84604619 |
| 139 | COPI coating of Golgi vesicle (GO:0048205) | 2.84554112 |
| 140 | Golgi transport vesicle coating (GO:0048200) | 2.84554112 |
| 141 | regulation of metalloenzyme activity (GO:0048552) | 2.78064938 |
| 142 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.75928827 |
| 143 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.74896356 |
| 144 | UTP biosynthetic process (GO:0006228) | 2.73947198 |
| 145 | L-ascorbic acid metabolic process (GO:0019852) | 2.73220658 |
| 146 | establishment of protein localization to mitochondrion (GO:0072655) | 2.69632155 |
| 147 | UTP metabolic process (GO:0046051) | 2.69117760 |
| 148 | adhesion of symbiont to host (GO:0044406) | 2.67278922 |
| 149 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 2.64929650 |
| 150 | positive regulation of mitochondrial fission (GO:0090141) | 2.63279030 |
| 151 | pyrimidine ribonucleoside triphosphate metabolic process (GO:0009208) | 2.61845725 |
| 152 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.61454640 |
| 153 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.59670109 |
| 154 | endosome to melanosome transport (GO:0035646) | 2.55718334 |
| 155 | endosome to pigment granule transport (GO:0043485) | 2.55718334 |
| 156 | mannosylation (GO:0097502) | 2.55690596 |
| 157 | cell redox homeostasis (GO:0045454) | 2.52673392 |
| 158 | response to redox state (GO:0051775) | 2.52478734 |
| 159 | protein hydroxylation (GO:0018126) | 2.51305272 |
| 160 | arginine catabolic process (GO:0006527) | 2.49734544 |
| 161 | protein localization to mitochondrion (GO:0070585) | 2.49165627 |
| 162 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.48132815 |
| 163 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.47398567 |
| 164 | negative regulation of mitochondrion organization (GO:0010823) | 2.46422266 |
| 165 | extracellular fibril organization (GO:0043206) | 2.46412792 |
| 166 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.45126607 |
| 167 | keratan sulfate catabolic process (GO:0042340) | 2.44213402 |
| 168 | positive regulation of actin filament depolymerization (GO:0030836) | 2.43324588 |
| 169 | cullin deneddylation (GO:0010388) | 2.43297070 |
| 170 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.39623800 |
| 171 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.39621609 |
| 172 | daunorubicin metabolic process (GO:0044597) | 2.39458357 |
| 173 | polyketide metabolic process (GO:0030638) | 2.39458357 |
| 174 | doxorubicin metabolic process (GO:0044598) | 2.39458357 |
| 175 | branched-chain amino acid catabolic process (GO:0009083) | 2.39075203 |
| 176 | iron-sulfur cluster assembly (GO:0016226) | 2.38092087 |
| 177 | metallo-sulfur cluster assembly (GO:0031163) | 2.38092087 |
| 178 | platelet dense granule organization (GO:0060155) | 2.37930009 |
| 179 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.33986887 |
| 180 | hyaluronan catabolic process (GO:0030214) | 2.33599682 |
| 181 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.33558506 |
| 182 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.33558506 |
| 183 | protein deneddylation (GO:0000338) | 2.32214461 |
| 184 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.30647206 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.94445364 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.31788465 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.84632715 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.18602141 |
| 5 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.16961906 |
| 6 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.21327792 |
| 7 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 4.17332673 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.15799195 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.98592742 |
| 10 | * HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.80489146 |
| 11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.65545909 |
| 12 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.55084850 |
| 13 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.49855483 |
| 14 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.29229807 |
| 15 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.19927587 |
| 16 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.18766173 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 2.16095563 |
| 18 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.00867291 |
| 19 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.0476835 |
| 20 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.89880170 |
| 21 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.80070094 |
| 22 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.77168264 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.77027431 |
| 24 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.76024733 |
| 25 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.69867125 |
| 26 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.68034914 |
| 27 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.67770839 |
| 28 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.64516858 |
| 29 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.63404050 |
| 30 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.61676153 |
| 31 | * CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.59441992 |
| 32 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.58292486 |
| 33 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.57452498 |
| 34 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.54644852 |
| 35 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.52103418 |
| 36 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.51783492 |
| 37 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.50922419 |
| 38 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.50412216 |
| 39 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.49290497 |
| 40 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.43250028 |
| 41 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.42755717 |
| 42 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.42697129 |
| 43 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.41058179 |
| 44 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.36895878 |
| 45 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.36310705 |
| 46 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.35786869 |
| 47 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.35075442 |
| 48 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.34911705 |
| 49 | * SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.34227789 |
| 50 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.33944041 |
| 51 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.33027585 |
| 52 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.32865134 |
| 53 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.31719474 |
| 54 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.29722075 |
| 55 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.29064737 |
| 56 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.28629595 |
| 57 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.28614358 |
| 58 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.27042896 |
| 59 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.25637717 |
| 60 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.25476229 |
| 61 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.20557902 |
| 62 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.20451707 |
| 63 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.15742297 |
| 64 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.15330074 |
| 65 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.14857706 |
| 66 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.14252413 |
| 67 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.13471231 |
| 68 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.13204920 |
| 69 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.13178846 |
| 70 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.12197163 |
| 71 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.08391963 |
| 72 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.08295837 |
| 73 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.07355440 |
| 74 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.06796270 |
| 75 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.05195534 |
| 76 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.05117352 |
| 77 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.04619260 |
| 78 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.04173280 |
| 79 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.02907441 |
| 80 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.00240251 |
| 81 | AR_20517297_ChIP-Seq_VCAP_Human | 0.99100656 |
| 82 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.98640533 |
| 83 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.98504262 |
| 84 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.98084237 |
| 85 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.96975193 |
| 86 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.96259056 |
| 87 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.96148467 |
| 88 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.96023667 |
| 89 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.95705384 |
| 90 | * SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.95240430 |
| 91 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.95225934 |
| 92 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.94733181 |
| 93 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.94685757 |
| 94 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.94163926 |
| 95 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.93366976 |
| 96 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.92458149 |
| 97 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.92448175 |
| 98 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.92261060 |
| 99 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.91458386 |
| 100 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 0.90308456 |
| 101 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.88336827 |
| 102 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.87580894 |
| 103 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.86723630 |
| 104 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.86589586 |
| 105 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.85807671 |
| 106 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.85321062 |
| 107 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.81923944 |
| 108 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.81922645 |
| 109 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.80330797 |
| 110 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.79080604 |
| 111 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.78561031 |
| 112 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.78528595 |
| 113 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.77651833 |
| 114 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.76350508 |
| 115 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.75340311 |
| 116 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.75109652 |
| 117 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.75040769 |
| 118 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.74493847 |
| 119 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.73719733 |
| 120 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.71585936 |
| 121 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.71217045 |
| 122 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.71217045 |
| 123 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.71092637 |
| 124 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.70682430 |
| 125 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.69287737 |
| 126 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.68730213 |
| 127 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.68458331 |
| 128 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.68122208 |
| 129 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.66497157 |
| 130 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.65872300 |
| 131 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.65341267 |
| 132 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.64767650 |
| 133 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.64588383 |
| 134 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.63468454 |
| 135 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.63300970 |
| 136 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.62791235 |
| 137 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.61329151 |
| 138 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.60929679 |
| 139 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.60213214 |
| 140 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.60163258 |
| 141 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.59953862 |
| 142 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.59369505 |
| 143 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.57864828 |
| 144 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.57004718 |
| 145 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.56975865 |
| 146 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.56650409 |
| 147 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.56272585 |
| 148 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.55652164 |
| 149 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.54883294 |
| 150 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.54688624 |
| 151 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.52783387 |
| 152 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.52741072 |
| 153 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.52601523 |
| 154 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.52206902 |
| 155 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.51971676 |
| 156 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.51643947 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.50908741 |
| 2 | MP0005360_urolithiasis | 6.28996068 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.60363662 |
| 4 | MP0005365_abnormal_bile_salt | 5.59027266 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 4.78360715 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.50605315 |
| 7 | MP0003195_calcinosis | 3.50312420 |
| 8 | MP0003252_abnormal_bile_duct | 3.25362605 |
| 9 | MP0009840_abnormal_foam_cell | 3.07843481 |
| 10 | MP0005257_abnormal_intraocular_pressure | 3.02192002 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.88920988 |
| 12 | MP0005083_abnormal_biliary_tract | 2.79221524 |
| 13 | MP0006054_spinal_hemorrhage | 2.69639147 |
| 14 | MP0005332_abnormal_amino_acid | 2.60661251 |
| 15 | MP0004272_abnormal_basement_membrane | 2.54858971 |
| 16 | MP0003279_aneurysm | 2.52616303 |
| 17 | MP0001666_abnormal_nutrient_absorption | 2.52163290 |
| 18 | MP0010030_abnormal_orbit_morphology | 2.49285401 |
| 19 | MP0000372_irregular_coat_pigmentation | 2.38229090 |
| 20 | MP0003123_paternal_imprinting | 2.18784029 |
| 21 | MP0003191_abnormal_cellular_cholesterol | 2.04473209 |
| 22 | MP0003950_abnormal_plasma_membrane | 2.01058355 |
| 23 | MP0003186_abnormal_redox_activity | 1.99492572 |
| 24 | MP0009697_abnormal_copulation | 1.98951953 |
| 25 | MP0002118_abnormal_lipid_homeostasis | 1.90274271 |
| 26 | MP0005451_abnormal_body_composition | 1.86581842 |
| 27 | MP0001764_abnormal_homeostasis | 1.84907453 |
| 28 | MP0002938_white_spotting | 1.83007118 |
| 29 | MP0000609_abnormal_liver_physiology | 1.81928024 |
| 30 | MP0003868_abnormal_feces_composition | 1.81338266 |
| 31 | MP0004019_abnormal_vitamin_homeostasis | 1.80582630 |
| 32 | MP0002138_abnormal_hepatobiliary_system | 1.66416180 |
| 33 | MP0002163_abnormal_gland_morphology | 1.65830531 |
| 34 | MP0005319_abnormal_enzyme/_coenzyme | 1.63480440 |
| 35 | MP0003011_delayed_dark_adaptation | 1.57667425 |
| 36 | MP0003656_abnormal_erythrocyte_physiolo | 1.57192283 |
| 37 | MP0003122_maternal_imprinting | 1.54194492 |
| 38 | MP0005408_hypopigmentation | 1.53917741 |
| 39 | MP0003172_abnormal_lysosome_physiology | 1.48308875 |
| 40 | MP0009780_abnormal_chondrocyte_physiolo | 1.48219984 |
| 41 | MP0008438_abnormal_cutaneous_collagen | 1.46876719 |
| 42 | MP0010386_abnormal_urinary_bladder | 1.44135276 |
| 43 | MP0009643_abnormal_urine_homeostasis | 1.42544554 |
| 44 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.41265282 |
| 45 | MP0005220_abnormal_exocrine_pancreas | 1.37269598 |
| 46 | MP0000013_abnormal_adipose_tissue | 1.31462715 |
| 47 | MP0005171_absent_coat_pigmentation | 1.31000146 |
| 48 | MP0005084_abnormal_gallbladder_morpholo | 1.29590400 |
| 49 | MP0000003_abnormal_adipose_tissue | 1.27314256 |
| 50 | MP0005508_abnormal_skeleton_morphology | 1.26863854 |
| 51 | MP0005503_abnormal_tendon_morphology | 1.23106680 |
| 52 | MP0005636_abnormal_mineral_homeostasis | 1.20037368 |
| 53 | MP0000358_abnormal_cell_content/ | 1.19141427 |
| 54 | MP0001958_emphysema | 1.18764340 |
| 55 | MP0000343_altered_response_to | 1.18722766 |
| 56 | MP0003724_increased_susceptibility_to | 1.17530940 |
| 57 | MP0010368_abnormal_lymphatic_system | 1.11082689 |
| 58 | MP0003718_maternal_effect | 1.07731722 |
| 59 | MP0000598_abnormal_liver_morphology | 1.07722417 |
| 60 | MP0001905_abnormal_dopamine_level | 1.06835889 |
| 61 | MP0006036_abnormal_mitochondrial_physio | 1.06457545 |
| 62 | MP0002837_dystrophic_cardiac_calcinosis | 1.03242221 |
| 63 | MP0009763_increased_sensitivity_to | 0.99379005 |
| 64 | MP0003786_premature_aging | 0.99179120 |
| 65 | MP0008469_abnormal_protein_level | 0.98383352 |
| 66 | MP0001542_abnormal_bone_strength | 0.97879714 |
| 67 | MP0009379_abnormal_foot_pigmentation | 0.96753698 |
| 68 | MP0005623_abnormal_meninges_morphology | 0.93449721 |
| 69 | MP0005647_abnormal_sex_gland | 0.90833936 |
| 70 | MP0009384_cardiac_valve_regurgitation | 0.90594580 |
| 71 | MP0009764_decreased_sensitivity_to | 0.89070769 |
| 72 | MP0002090_abnormal_vision | 0.88890513 |
| 73 | MP0005058_abnormal_lysosome_morphology | 0.88724201 |
| 74 | MP0001661_extended_life_span | 0.88531377 |
| 75 | MP0000015_abnormal_ear_pigmentation | 0.86687042 |
| 76 | MP0000681_abnormal_thyroid_gland | 0.86299183 |
| 77 | MP0001529_abnormal_vocalization | 0.84154238 |
| 78 | MP0008260_abnormal_autophagy | 0.83771748 |
| 79 | * MP0009642_abnormal_blood_homeostasis | 0.83662203 |
| 80 | MP0002876_abnormal_thyroid_physiology | 0.83539698 |
| 81 | MP0000750_abnormal_muscle_regeneration | 0.83290511 |
| 82 | MP0009765_abnormal_xenobiotic_induced | 0.83112885 |
| 83 | MP0005376_homeostasis/metabolism_phenot | 0.82416538 |
| 84 | MP0005197_abnormal_uvea_morphology | 0.81772375 |
| 85 | MP0008789_abnormal_olfactory_epithelium | 0.81572952 |
| 86 | MP0000639_abnormal_adrenal_gland | 0.81542707 |
| 87 | MP0002295_abnormal_pulmonary_circulatio | 0.80925878 |
| 88 | MP0002909_abnormal_adrenal_gland | 0.80694636 |
| 89 | MP0003942_abnormal_urinary_system | 0.79174283 |
| 90 | MP0005193_abnormal_anterior_eye | 0.78244249 |
| 91 | MP0004858_abnormal_nervous_system | 0.77677574 |
| 92 | MP0003566_abnormal_cell_adhesion | 0.75772885 |
| 93 | MP0005670_abnormal_white_adipose | 0.75174430 |
| 94 | MP0001243_abnormal_dermal_layer | 0.74496755 |
| 95 | MP0004381_abnormal_hair_follicle | 0.74253540 |
| 96 | MP0008932_abnormal_embryonic_tissue | 0.73580550 |
| 97 | MP0002060_abnormal_skin_morphology | 0.73325226 |
| 98 | MP0000604_amyloidosis | 0.72971805 |
| 99 | MP0002933_joint_inflammation | 0.72829177 |
| 100 | MP0004043_abnormal_pH_regulation | 0.72165164 |
| 101 | MP0005165_increased_susceptibility_to | 0.72017379 |
| 102 | MP0003121_genomic_imprinting | 0.70971979 |
| 103 | MP0005395_other_phenotype | 0.70880809 |
| 104 | MP0005379_endocrine/exocrine_gland_phen | 0.70684509 |
| 105 | MP0001756_abnormal_urination | 0.69833505 |
| 106 | MP0005275_abnormal_skin_tensile | 0.68410211 |
| 107 | MP0002078_abnormal_glucose_homeostasis | 0.68405614 |
| 108 | MP0004147_increased_porphyrin_level | 0.67476288 |
| 109 | MP0002160_abnormal_reproductive_system | 0.65826681 |
| 110 | MP0002254_reproductive_system_inflammat | 0.64641449 |
| 111 | MP0003075_altered_response_to | 0.63937277 |
| 112 | MP0001324_abnormal_eye_pigmentation | 0.63825963 |
| 113 | MP0009250_abnormal_appendicular_skeleto | 0.63746424 |
| 114 | MP0005410_abnormal_fertilization | 0.62465178 |
| 115 | MP0006082_CNS_inflammation | 0.61487195 |
| 116 | MP0009053_abnormal_anal_canal | 0.61251130 |
| 117 | MP0003638_abnormal_response/metabolism_ | 0.60921647 |
| 118 | MP0005646_abnormal_pituitary_gland | 0.60055401 |
| 119 | MP0006292_abnormal_olfactory_placode | 0.59846979 |
| 120 | MP0004782_abnormal_surfactant_physiolog | 0.59284632 |
| 121 | MP0001533_abnormal_skeleton_physiology | 0.59132500 |
| 122 | MP0005075_abnormal_melanosome_morpholog | 0.58453971 |
| 123 | MP0003690_abnormal_glial_cell | 0.57815314 |
| 124 | MP0005464_abnormal_platelet_physiology | 0.57584954 |
| 125 | MP0001944_abnormal_pancreas_morphology | 0.56785894 |
| 126 | MP0005164_abnormal_response_to | 0.55240054 |
| 127 | MP0003705_abnormal_hypodermis_morpholog | 0.54504037 |
| 128 | MP0003436_decreased_susceptibility_to | 0.53482393 |
| 129 | MP0000230_abnormal_systemic_arterial | 0.52247734 |
| 130 | MP0002132_abnormal_respiratory_system | 0.51690491 |
| 131 | MP0004134_abnormal_chest_morphology | 0.51389729 |
| 132 | MP0000163_abnormal_cartilage_morphology | 0.50946492 |
| 133 | MP0000920_abnormal_myelination | 0.50673192 |
| 134 | MP0005266_abnormal_metabolism | 0.49719267 |
| 135 | MP0005334_abnormal_fat_pad | 0.47036565 |
| 136 | MP0005535_abnormal_body_temperature | 0.45187712 |
| 137 | MP0002136_abnormal_kidney_physiology | 0.44955965 |
| 138 | MP0008873_increased_physiological_sensi | 0.43757473 |
| 139 | MP0000613_abnormal_salivary_gland | 0.42923032 |
| 140 | MP0006035_abnormal_mitochondrial_morpho | 0.40537929 |
| 141 | MP0005023_abnormal_wound_healing | 0.39883025 |
| 142 | MP0005595_abnormal_vascular_smooth | 0.39865431 |
| 143 | MP0001845_abnormal_inflammatory_respons | 0.39501148 |
| 144 | MP0000566_synostosis | 0.38575122 |
| 145 | MP0005390_skeleton_phenotype | 0.36986875 |
| 146 | MP0002971_abnormal_brown_adipose | 0.36933785 |
| 147 | MP0003953_abnormal_hormone_level | 0.36740369 |
| 148 | MP0000579_abnormal_nail_morphology | 0.36618091 |
| 149 | MP0000538_abnormal_urinary_bladder | 0.36544983 |
| 150 | MP0002693_abnormal_pancreas_physiology | 0.35314658 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.26218508 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.21929188 |
| 3 | Prolonged partial thromboplastin time (HP:0003645) | 5.87505123 |
| 4 | Deep venous thrombosis (HP:0002625) | 5.68073900 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.31403301 |
| 6 | Xanthomatosis (HP:0000991) | 5.06377384 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 5.02094313 |
| 8 | Premature rupture of membranes (HP:0001788) | 4.83687699 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 4.55039746 |
| 10 | Complement deficiency (HP:0004431) | 4.22915947 |
| 11 | Hypoglycemic coma (HP:0001325) | 4.08951514 |
| 12 | Joint hemorrhage (HP:0005261) | 3.89685967 |
| 13 | Fat malabsorption (HP:0002630) | 3.81784509 |
| 14 | Abnormality of methionine metabolism (HP:0010901) | 3.81596934 |
| 15 | Protrusio acetabuli (HP:0003179) | 3.73138582 |
| 16 | Hypolipoproteinemia (HP:0010981) | 3.67840936 |
| 17 | Hyperammonemia (HP:0001987) | 3.65041277 |
| 18 | Hyperglycinemia (HP:0002154) | 3.64861077 |
| 19 | Ketosis (HP:0001946) | 3.61085938 |
| 20 | Acute necrotizing encephalopathy (HP:0006965) | 3.58215814 |
| 21 | * Abnormality of the common coagulation pathway (HP:0010990) | 3.55326021 |
| 22 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.53553293 |
| 23 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.52728699 |
| 24 | Vertebral compression fractures (HP:0002953) | 3.51064655 |
| 25 | * Abnormality of the intrinsic pathway (HP:0010989) | 3.45914359 |
| 26 | Conjugated hyperbilirubinemia (HP:0002908) | 3.42928479 |
| 27 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.39909761 |
| 28 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.37704655 |
| 29 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.33634912 |
| 30 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.30697145 |
| 31 | Mitochondrial inheritance (HP:0001427) | 3.28502135 |
| 32 | Abnormality of glycolysis (HP:0004366) | 3.24072032 |
| 33 | Steatorrhea (HP:0002570) | 3.21449144 |
| 34 | Generalized aminoaciduria (HP:0002909) | 3.18021054 |
| 35 | Prolonged neonatal jaundice (HP:0006579) | 3.17880159 |
| 36 | Abnormality of complement system (HP:0005339) | 3.16773145 |
| 37 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.16272445 |
| 38 | Abnormality of glycine metabolism (HP:0010895) | 3.16272445 |
| 39 | Hypoalphalipoproteinemia (HP:0003233) | 3.14246311 |
| 40 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.09933106 |
| 41 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.07994367 |
| 42 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.07994367 |
| 43 | Abnormality of glycolipid metabolism (HP:0010969) | 3.07994367 |
| 44 | Increased serum pyruvate (HP:0003542) | 3.05340565 |
| 45 | Hyperbilirubinemia (HP:0002904) | 3.01715370 |
| 46 | Epidermoid cyst (HP:0200040) | 3.00977425 |
| 47 | Hyperglycinuria (HP:0003108) | 2.95360859 |
| 48 | Increased CSF lactate (HP:0002490) | 2.88953266 |
| 49 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.84793414 |
| 50 | Dicarboxylic aciduria (HP:0003215) | 2.81686677 |
| 51 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.81686677 |
| 52 | Cerebral edema (HP:0002181) | 2.78808605 |
| 53 | Abnormal tarsal ossification (HP:0008369) | 2.77235887 |
| 54 | Progressive macrocephaly (HP:0004481) | 2.77227319 |
| 55 | Delayed CNS myelination (HP:0002188) | 2.76998970 |
| 56 | Systemic lupus erythematosus (HP:0002725) | 2.75607865 |
| 57 | Hypoglycemic seizures (HP:0002173) | 2.69916356 |
| 58 | Follicular hyperkeratosis (HP:0007502) | 2.69748430 |
| 59 | Abnormality of serum amino acid levels (HP:0003112) | 2.67124178 |
| 60 | Lethargy (HP:0001254) | 2.66781184 |
| 61 | Abnormality of dentin (HP:0010299) | 2.66460506 |
| 62 | Ketoacidosis (HP:0001993) | 2.64560465 |
| 63 | Type I transferrin isoform profile (HP:0003642) | 2.59845358 |
| 64 | Ankle contracture (HP:0006466) | 2.58193020 |
| 65 | Hepatic necrosis (HP:0002605) | 2.54587099 |
| 66 | Dysostosis multiplex (HP:0000943) | 2.51623417 |
| 67 | Spontaneous abortion (HP:0005268) | 2.50987268 |
| 68 | Opisthotonus (HP:0002179) | 2.50739521 |
| 69 | Hypercholesterolemia (HP:0003124) | 2.50551196 |
| 70 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.50405606 |
| 71 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.50405606 |
| 72 | Metabolic acidosis (HP:0001942) | 2.46511682 |
| 73 | Abnormality of nucleobase metabolism (HP:0010932) | 2.41852428 |
| 74 | Cervical subluxation (HP:0003308) | 2.41198014 |
| 75 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.39784804 |
| 76 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.39784804 |
| 77 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.39784804 |
| 78 | Acute encephalopathy (HP:0006846) | 2.35530235 |
| 79 | Glycosuria (HP:0003076) | 2.34332837 |
| 80 | Abnormality of urine glucose concentration (HP:0011016) | 2.34332837 |
| 81 | Beaking of vertebral bodies (HP:0004568) | 2.31555148 |
| 82 | Soft skin (HP:0000977) | 2.31374387 |
| 83 | Brushfield spots (HP:0001088) | 2.27695717 |
| 84 | Nuclear cataract (HP:0100018) | 2.26790364 |
| 85 | Hepatocellular carcinoma (HP:0001402) | 2.25379559 |
| 86 | Mucopolysacchariduria (HP:0008155) | 2.24155628 |
| 87 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.24155628 |
| 88 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.23875977 |
| 89 | Symptomatic seizures (HP:0011145) | 2.22572971 |
| 90 | Glomerulonephritis (HP:0000099) | 2.22380633 |
| 91 | Abnormality of purine metabolism (HP:0004352) | 2.20381935 |
| 92 | Amyloidosis (HP:0011034) | 2.19980292 |
| 93 | Progressive neurologic deterioration (HP:0002344) | 2.18086199 |
| 94 | Respiratory failure (HP:0002878) | 2.17549076 |
| 95 | Irritability (HP:0000737) | 2.16451130 |
| 96 | Exercise intolerance (HP:0003546) | 2.14200658 |
| 97 | Vomiting (HP:0002013) | 2.12942449 |
| 98 | Vascular calcification (HP:0004934) | 2.12643170 |
| 99 | Reduced antithrombin III activity (HP:0001976) | 2.12086343 |
| 100 | Hypokinesia (HP:0002375) | 2.11883108 |
| 101 | Hand muscle atrophy (HP:0009130) | 2.11867486 |
| 102 | Lactic acidosis (HP:0003128) | 2.11430368 |
| 103 | Enlarged kidneys (HP:0000105) | 2.11098860 |
| 104 | Pancreatitis (HP:0001733) | 2.10866957 |
| 105 | Renal Fanconi syndrome (HP:0001994) | 2.08831552 |
| 106 | Protuberant abdomen (HP:0001538) | 2.07560930 |
| 107 | Increased serum lactate (HP:0002151) | 2.04670975 |
| 108 | Abnormal cartilage morphology (HP:0002763) | 2.04033442 |
| 109 | Malnutrition (HP:0004395) | 2.03443708 |
| 110 | Renal cortical cysts (HP:0000803) | 2.03013365 |
| 111 | Abnormal protein glycosylation (HP:0012346) | 2.02124801 |
| 112 | Abnormal glycosylation (HP:0012345) | 2.02124801 |
| 113 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.02124801 |
| 114 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.02124801 |
| 115 | Gout (HP:0001997) | 1.98384244 |
| 116 | Late onset (HP:0003584) | 1.98094081 |
| 117 | Redundant skin (HP:0001582) | 1.97859483 |
| 118 | Myocardial infarction (HP:0001658) | 1.97804195 |
| 119 | Purpura (HP:0000979) | 1.96853682 |
| 120 | Cardiovascular calcification (HP:0011915) | 1.95845385 |
| 121 | Increased intramyocellular lipid droplets (HP:0012240) | 1.95251730 |
| 122 | Joint stiffness (HP:0001387) | 1.94837572 |
| 123 | Skin nodule (HP:0200036) | 1.93990670 |
| 124 | Microvesicular hepatic steatosis (HP:0001414) | 1.93954825 |
| 125 | Increased hepatocellular lipid droplets (HP:0006565) | 1.93781759 |
| 126 | Hepatocellular necrosis (HP:0001404) | 1.93526790 |
| 127 | Menorrhagia (HP:0000132) | 1.92413873 |
| 128 | Irregular epiphyses (HP:0010582) | 1.91947358 |
| 129 | Abnormal gallbladder morphology (HP:0012437) | 1.91937092 |
| 130 | Proximal tubulopathy (HP:0000114) | 1.90153035 |
| 131 | Blue sclerae (HP:0000592) | 1.87590786 |
| 132 | Spastic paraparesis (HP:0002313) | 1.86502379 |
| 133 | Cholecystitis (HP:0001082) | 1.86410393 |
| 134 | Abnormal gallbladder physiology (HP:0012438) | 1.86410393 |
| 135 | 3-Methylglutaconic aciduria (HP:0003535) | 1.85920973 |
| 136 | Abnormality of the Achilles tendon (HP:0005109) | 1.84537816 |
| 137 | Lipid accumulation in hepatocytes (HP:0006561) | 1.83338147 |
| 138 | Gingival bleeding (HP:0000225) | 1.82567075 |
| 139 | Exertional dyspnea (HP:0002875) | 1.82137582 |
| 140 | J-shaped sella turcica (HP:0002680) | 1.81305400 |
| 141 | Epiphyseal stippling (HP:0010655) | 1.81066545 |
| 142 | Vacuolated lymphocytes (HP:0001922) | 1.80155474 |
| 143 | Mitral stenosis (HP:0001718) | 1.80045550 |
| 144 | Rickets (HP:0002748) | 1.79176099 |
| 145 | Hypophosphatemic rickets (HP:0004912) | 1.79068565 |
| 146 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.78970952 |
| 147 | Petechiae (HP:0000967) | 1.78391497 |
| 148 | Testicular atrophy (HP:0000029) | 1.78312419 |
| 149 | Hyperglycemia (HP:0003074) | 1.78247040 |
| 150 | Hyperthyroidism (HP:0000836) | 1.77525161 |
| 151 | Generalized amyotrophy (HP:0003700) | 1.77247960 |
| 152 | Elevated hepatic transaminases (HP:0002910) | 1.77247697 |
| 153 | Microretrognathia (HP:0000308) | 1.76221577 |
| 154 | Abnormality of iron homeostasis (HP:0011031) | 1.75367040 |
| 155 | Craniofacial dystonia (HP:0012179) | 1.74962312 |
| 156 | Distal upper limb amyotrophy (HP:0007149) | 1.74452703 |
| 157 | Upper limb amyotrophy (HP:0009129) | 1.74452703 |
| 158 | Elbow flexion contracture (HP:0002987) | 1.72614008 |
| 159 | Adrenal hypoplasia (HP:0000835) | 1.72569549 |
| 160 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.72150216 |
| 161 | Delayed gross motor development (HP:0002194) | 1.72145224 |
| 162 | Abnormal delivery (HP:0001787) | 1.70107132 |
| 163 | Emotional lability (HP:0000712) | 1.68200631 |
| 164 | Focal dystonia (HP:0004373) | 1.67513604 |
| 165 | Increased muscle lipid content (HP:0009058) | 1.67057149 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.28318431 |
| 2 | TESK1 | 4.00922357 |
| 3 | LIMK1 | 3.81319447 |
| 4 | VRK2 | 3.47334654 |
| 5 | ERN1 | 3.39243669 |
| 6 | INSRR | 2.96172075 |
| 7 | NME2 | 2.89695545 |
| 8 | STK16 | 2.65965411 |
| 9 | TAOK3 | 2.65544071 |
| 10 | MAPK15 | 2.37930367 |
| 11 | PIK3CG | 2.36540508 |
| 12 | MAP4K2 | 2.28379189 |
| 13 | FGFR4 | 2.25319928 |
| 14 | SIK1 | 2.20446188 |
| 15 | PBK | 2.07788331 |
| 16 | MAP3K3 | 2.02232667 |
| 17 | ERBB4 | 1.92550889 |
| 18 | EIF2AK3 | 1.84001197 |
| 19 | DDR2 | 1.82538928 |
| 20 | PIM2 | 1.81958368 |
| 21 | FLT3 | 1.78046545 |
| 22 | PDK2 | 1.77381207 |
| 23 | IRAK3 | 1.73896719 |
| 24 | ABL2 | 1.70418895 |
| 25 | BUB1 | 1.69826114 |
| 26 | STK39 | 1.64154980 |
| 27 | ILK | 1.60679112 |
| 28 | MET | 1.59961744 |
| 29 | MAPKAPK5 | 1.53021700 |
| 30 | PAK4 | 1.44840578 |
| 31 | EPHB2 | 1.41142822 |
| 32 | EPHB1 | 1.39964465 |
| 33 | EIF2AK1 | 1.36175263 |
| 34 | KDR | 1.35344639 |
| 35 | ARAF | 1.33975367 |
| 36 | PTK2 | 1.33531921 |
| 37 | MST1R | 1.30111060 |
| 38 | WNK4 | 1.28920265 |
| 39 | MAP3K12 | 1.24007144 |
| 40 | PRKD3 | 1.21644672 |
| 41 | DAPK3 | 1.17300609 |
| 42 | DAPK1 | 1.16921869 |
| 43 | TIE1 | 1.15962384 |
| 44 | TRIM28 | 1.15262894 |
| 45 | VRK1 | 1.14652463 |
| 46 | BMPR1B | 1.14634311 |
| 47 | PAK1 | 1.13499930 |
| 48 | IRAK4 | 1.12371678 |
| 49 | NEK1 | 1.11525563 |
| 50 | NEK9 | 1.09915667 |
| 51 | TYK2 | 1.08407890 |
| 52 | IRAK1 | 1.08021167 |
| 53 | BRSK1 | 1.06977167 |
| 54 | BRAF | 1.05928218 |
| 55 | STK38L | 1.04925517 |
| 56 | MAP2K3 | 1.03848253 |
| 57 | AURKA | 0.99949441 |
| 58 | OXSR1 | 0.99374630 |
| 59 | FRK | 0.99212270 |
| 60 | MAP2K2 | 0.96781562 |
| 61 | MAPK11 | 0.96396901 |
| 62 | LMTK2 | 0.95372348 |
| 63 | TGFBR2 | 0.92790307 |
| 64 | MAP2K7 | 0.92023586 |
| 65 | EPHA3 | 0.90766514 |
| 66 | PINK1 | 0.89442527 |
| 67 | BMPR2 | 0.88277744 |
| 68 | CSNK1G1 | 0.87362830 |
| 69 | CSNK1G3 | 0.86461241 |
| 70 | TBK1 | 0.84464591 |
| 71 | ACVR1B | 0.84033455 |
| 72 | ADRBK2 | 0.82447491 |
| 73 | PLK3 | 0.82162574 |
| 74 | TAOK2 | 0.80961494 |
| 75 | NLK | 0.80692801 |
| 76 | KIT | 0.79645778 |
| 77 | PKN2 | 0.79457394 |
| 78 | MUSK | 0.79165462 |
| 79 | TESK2 | 0.76664311 |
| 80 | PAK2 | 0.76345671 |
| 81 | MYLK | 0.75931764 |
| 82 | TGFBR1 | 0.73464818 |
| 83 | DYRK2 | 0.73463746 |
| 84 | IKBKB | 0.70707847 |
| 85 | PASK | 0.69431413 |
| 86 | TEC | 0.69200637 |
| 87 | MAPKAPK3 | 0.68799920 |
| 88 | IKBKE | 0.68529822 |
| 89 | NUAK1 | 0.68413700 |
| 90 | PRKCI | 0.67911849 |
| 91 | PRKD2 | 0.66404378 |
| 92 | MAPK4 | 0.64596431 |
| 93 | MAP3K11 | 0.64161878 |
| 94 | PRKG2 | 0.63821348 |
| 95 | GRK5 | 0.63790311 |
| 96 | CAMK2G | 0.63601357 |
| 97 | PLK4 | 0.62079079 |
| 98 | MAP2K6 | 0.61490904 |
| 99 | RPS6KA4 | 0.60026536 |
| 100 | GRK1 | 0.59801128 |
| 101 | WNK3 | 0.58625331 |
| 102 | CDK14 | 0.57218785 |
| 103 | PLK2 | 0.56901460 |
| 104 | PLK1 | 0.55667218 |
| 105 | ADRBK1 | 0.55008330 |
| 106 | FGFR2 | 0.54432524 |
| 107 | PAK3 | 0.52713032 |
| 108 | GSK3A | 0.52320923 |
| 109 | PRKCG | 0.52066003 |
| 110 | TRPM7 | 0.51127350 |
| 111 | IRAK2 | 0.50682670 |
| 112 | EPHA2 | 0.50653035 |
| 113 | MST4 | 0.50498936 |
| 114 | RPS6KA5 | 0.50293513 |
| 115 | CAMK2D | 0.50125458 |
| 116 | BTK | 0.49928195 |
| 117 | CSNK1A1L | 0.49364291 |
| 118 | GRK7 | 0.49330431 |
| 119 | PAK6 | 0.47789720 |
| 120 | ZAK | 0.47707926 |
| 121 | BMX | 0.47335620 |
| 122 | LRRK2 | 0.45013531 |
| 123 | MOS | 0.44934054 |
| 124 | ZAP70 | 0.44386009 |
| 125 | CSNK2A2 | 0.44042745 |
| 126 | PRKCE | 0.43964861 |
| 127 | AKT2 | 0.43387685 |
| 128 | JAK2 | 0.43040461 |
| 129 | CDK11A | 0.42755371 |
| 130 | CDK15 | 0.41671359 |
| 131 | PHKG2 | 0.40961601 |
| 132 | PHKG1 | 0.40961601 |
| 133 | CDK18 | 0.40433288 |
| 134 | CSNK2A1 | 0.40206818 |
| 135 | EIF2AK2 | 0.39581318 |
| 136 | MAP3K8 | 0.38971895 |
| 137 | MAP3K6 | 0.37216184 |
| 138 | LYN | 0.36263801 |
| 139 | CSF1R | 0.35700534 |
| 140 | DYRK3 | 0.35565929 |
| 141 | CDK8 | 0.35388094 |
| 142 | LATS1 | 0.34899453 |
| 143 | BRSK2 | 0.34649644 |
| 144 | STK4 | 0.34303466 |
| 145 | BLK | 0.34264977 |
| 146 | CDK19 | 0.32561206 |
| 147 | ERBB2 | 0.32472478 |
| 148 | PRKAA2 | 0.31638217 |
| 149 | CDK7 | 0.31503717 |
| 150 | MAPK7 | 0.31131750 |
| 151 | MAP3K14 | 0.30097910 |
| 152 | TNIK | 0.29943936 |
| 153 | IGF1R | 0.29849940 |
| 154 | CSNK1G2 | 0.29226879 |
| 155 | PTK2B | 0.29221695 |
| 156 | AURKB | 0.29203982 |
| 157 | CHEK2 | 0.29182390 |
| 158 | STK38 | 0.28240147 |
| 159 | STK3 | 0.26941496 |
| 160 | PRKD1 | 0.26265729 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.00219728 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.98151288 |
| 3 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.71693542 |
| 4 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.60738935 |
| 5 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.46693022 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.38835893 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.37470924 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.33190186 |
| 9 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.24215956 |
| 10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.23074404 |
| 11 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.17202882 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.16833030 |
| 13 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.16304722 |
| 14 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.15017409 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.12576364 |
| 16 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.09880888 |
| 17 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.08509744 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 2.07396772 |
| 19 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.00377297 |
| 20 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.00132743 |
| 21 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.97758067 |
| 22 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.96318603 |
| 23 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.92825407 |
| 24 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.92325477 |
| 25 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.90822907 |
| 26 | Protein export_Homo sapiens_hsa03060 | 1.86939945 |
| 27 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.85414124 |
| 28 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.77487316 |
| 29 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.75518131 |
| 30 | * Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.73830326 |
| 31 | Retinol metabolism_Homo sapiens_hsa00830 | 1.64752779 |
| 32 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.61992104 |
| 33 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.54477936 |
| 34 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.54026333 |
| 35 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.53956705 |
| 36 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.53792317 |
| 37 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.51136964 |
| 38 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.46598585 |
| 39 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.43955827 |
| 40 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.43282544 |
| 41 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.41764175 |
| 42 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.32294600 |
| 43 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.24442457 |
| 44 | Base excision repair_Homo sapiens_hsa03410 | 1.23569007 |
| 45 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.22907431 |
| 46 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.22449501 |
| 47 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.20304020 |
| 48 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.17077523 |
| 49 | Sulfur relay system_Homo sapiens_hsa04122 | 1.14656076 |
| 50 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.13767883 |
| 51 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.12386759 |
| 52 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.10848430 |
| 53 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.10251865 |
| 54 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.07543254 |
| 55 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.02979677 |
| 56 | DNA replication_Homo sapiens_hsa03030 | 0.98065213 |
| 57 | ABC transporters_Homo sapiens_hsa02010 | 0.97250765 |
| 58 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.96371219 |
| 59 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.92223930 |
| 60 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.91010256 |
| 61 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.90604483 |
| 62 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.88048102 |
| 63 | Mismatch repair_Homo sapiens_hsa03430 | 0.87860605 |
| 64 | Bile secretion_Homo sapiens_hsa04976 | 0.87751021 |
| 65 | Carbon metabolism_Homo sapiens_hsa01200 | 0.86937668 |
| 66 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.80963585 |
| 67 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.77865941 |
| 68 | Metabolic pathways_Homo sapiens_hsa01100 | 0.75950379 |
| 69 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.73824437 |
| 70 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.71557224 |
| 71 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.70760392 |
| 72 | Mineral absorption_Homo sapiens_hsa04978 | 0.70574029 |
| 73 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.69795485 |
| 74 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.68529331 |
| 75 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.68230538 |
| 76 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.68003565 |
| 77 | Ribosome_Homo sapiens_hsa03010 | 0.67890345 |
| 78 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.63316669 |
| 79 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.61045554 |
| 80 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.58125945 |
| 81 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.55999587 |
| 82 | Proteasome_Homo sapiens_hsa03050 | 0.55804207 |
| 83 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.55405729 |
| 84 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.54854851 |
| 85 | Homologous recombination_Homo sapiens_hsa03440 | 0.53851828 |
| 86 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.53676567 |
| 87 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.51372811 |
| 88 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.48667721 |
| 89 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.47727205 |
| 90 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.46378948 |
| 91 | Parkinsons disease_Homo sapiens_hsa05012 | 0.46331238 |
| 92 | Other glycan degradation_Homo sapiens_hsa00511 | 0.46203982 |
| 93 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.45946169 |
| 94 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.44785912 |
| 95 | Galactose metabolism_Homo sapiens_hsa00052 | 0.43621106 |
| 96 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.40221359 |
| 97 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.39456476 |
| 98 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.38702166 |
| 99 | Lysine degradation_Homo sapiens_hsa00310 | 0.37486627 |
| 100 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.34784845 |
| 101 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.34293054 |
| 102 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.33009652 |
| 103 | RNA polymerase_Homo sapiens_hsa03020 | 0.31733699 |
| 104 | Prion diseases_Homo sapiens_hsa05020 | 0.29153292 |
| 105 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.27184729 |
| 106 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.25066029 |
| 107 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.22256937 |
| 108 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.21979139 |
| 109 | Alzheimers disease_Homo sapiens_hsa05010 | 0.20799195 |
| 110 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.19352400 |
| 111 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.19232980 |
| 112 | Lysosome_Homo sapiens_hsa04142 | 0.13212147 |
| 113 | Huntingtons disease_Homo sapiens_hsa05016 | 0.13152268 |
| 114 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.12844690 |
| 115 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.12586410 |
| 116 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.12092305 |
| 117 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.10286401 |
| 118 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.09556853 |
| 119 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.07033999 |
| 120 | Purine metabolism_Homo sapiens_hsa00230 | 0.04900189 |

